KALA BIO (KALA) Competitors

KALA BIO (NASDAQ:KALA) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Does the media favor KALA or CRGX?

In the previous week, CARGO Therapeutics had 1 more articles in the media than KALA BIO. MarketBeat recorded 3 mentions for CARGO Therapeutics and 2 mentions for KALA BIO. KALA BIO's average media sentiment score of 0.94 beat CARGO Therapeutics' score of 0.38 indicating that KALA BIO is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KALA BIO	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CARGO Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend KALA or CRGX?

KALA BIO presently has a consensus price target of $13.00, indicating a potential upside of 41.15%. CARGO Therapeutics has a consensus price target of $15.40, indicating a potential upside of 244.52%. Given CARGO Therapeutics' higher probable upside, analysts plainly believe CARGO Therapeutics is more favorable than KALA BIO.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KALA BIO	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
CARGO Therapeutics	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86

Which has more volatility and risk, KALA or CRGX?

KALA BIO has a beta of -1.81, meaning that its stock price is 281% less volatile than the S&P 500. Comparatively, CARGO Therapeutics has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500.

Is KALA or CRGX more profitable?

CARGO Therapeutics' return on equity of -43.21% beat KALA BIO's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KALA BIO	N/A	-686.43%	-76.81%
CARGO Therapeutics	N/A	-43.21%	-37.26%

Which has preferable earnings & valuation, KALA or CRGX?

KALA BIO has higher revenue and earnings than CARGO Therapeutics. KALA BIO is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KALA BIO	$3.89M	16.62	-$38.51M	-$6.79	-1.36
CARGO Therapeutics	N/A	N/A	-$167.50M	-$4.64	-0.96

Do insiders and institutionals believe in KALA or CRGX?

24.6% of KALA BIO shares are owned by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are owned by institutional investors. 8.3% of KALA BIO shares are owned by insiders. Comparatively, 2.9% of CARGO Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

CARGO Therapeutics beats KALA BIO on 8 of the 14 factors compared between the two stocks.